Stellah Mpagama

Stellah Mpagama is an Honorary Professor at the School of Medicine, University of St Andrews, contributing to research in pharmacology and infectious diseases with a focus on tuberculosis treatment. Her work intersects with global health initiatives, particularly under the UN Sustainable Development Goals.

• Research Focus: Pharmacokinetics, antimicrobial chemotherapy, and drug safety evaluation.
• Key Collaborations: Active involvement with the PanACEA Consortium for tuberculosis drug development.

Her recent publications analyze the safety and pharmacokinetics of novel and existing anti-TB drugs, such as bedaquiline, delamanid, sutezolid, and BTZ-043. These studies address critical gaps in tuberculosis treatment regimens and drug interaction dynamics.

While no awards or student advisement details are publicly listed, her research output has garnered attention across academic platforms (e.g., 41 Mendeley readers) and media outlets, indicating significant impact in pharmacological and clinical domains.